TAIWAN · TWSE / TPEx
StemCyte
永笙-KY · 4178 · TWSE (main board) · Biotech and medical
Share price, 2026-10-19NT$17.201 month +4.6% · 1 year -28.2%
Directors and supervisors hold49,578,13723.0% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold32,937,15015.3% of shares issued
Revenue, 2026-09+28.2%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 王嘉宗 | Chairman | 2,835,563 | 2,835,563 | 1.31% | — | 872,781 |
| 鑽石生技投資(股)公司 | Vice chairman · Director · Major shareholder (10%+) | 18,433,150 | 32,937,150 | 15.26% | — | 15,000,000 |
| 路孔明 | Vice chairman (corporate representative) · President | — | 0 | — | — | — |
| 鄭志慧 | Director (corporate representative) | — | 0 | — | — | 206,559 |
| 路景宏 | Director (corporate representative) | — | 0 | — | — | — |
| 富邦金控創業投資股份有限公司 | Director | 14,075,424 | 13,805,424 | 6.39% | — | — |
| 林慧芬 | Director (corporate representative) | — | 14,000 | 0.01% | — | — |
| 何弘能 | Independent director | — | 0 | — | — | — |
| 韓立群 | Independent director | — | 0 | — | — | — |
| 劉玄哲 | Independent director | — | 0 | — | — | — |
| 張碩修 | Manager | — | 0 | — | — | — |
| 陳怡儒 | Chief financial officer · Chief accountant · Other | — | 33,000 | 0.02% | — | — |
| 蘇郁清 | Other | — | 188,000 | 0.09% | — | — |
| 戴榮國 | Other | — | 0 | — | — | — |
| 邱佳玲 | Other | — | 50,000 | 0.02% | — | — |